The project outcome is a disc-shaped platform, the “LabDisk”, which integrates all biochemical components that are needed for a fully automated analysis within about 1.5 hour after inserting a small amount of blood (200µL) and simply pressing the “Start” button of a compact, portable device. This is a revolutionary change in the diagnosis concept (at the point of need) and methodology (detecting the “genetic fingerprint” of the pathogens.

In his blog, published on the occasion of the World Malaria Day, Dr. Konstantinos Mitsakakis explains what are the biggest achievements of the project and how it can help fight malaria.

The platform created via this project can detect any of the three main classes of pathogens (parasites, bacteria, and viruses) thereby assisting the clinician towards the proper treatment decision. This enables the consortium to adapt the combination of biochemical reagents to detect additional diseases according to the global health needs. This high degree of adaptability is one of the most innovative features of the LabDisk.

The project has also contributed to capacity building in Africa by means of installing one device in Dakar and training the personnel to its use. In this way, a sustainable use at the point of need is ensured. Due to the current Zika virus outbreak, the project partners have expressed their motivation to integrate this virus in the detection panel, thereby responding to the epidemic in a fast, coordinated and efficient way.